Regulus Therapeutics
Claire Padgett, PhD, currently serves as Senior Vice President of Clinical Operations at Regulus Therapeutics, a position held since December 2022. Prior to this role, Claire Padgett was Principal Consultant at Constellation Consulting LLC and held various senior leadership positions in clinical operations at Sanifit Therapeutics, Mirati Therapeutics, Mast Therapeutics, and Cylene Pharmaceuticals. Claire Padgett possesses significant expertise in the pharmaceutical industry, supported by an educational background that includes a PhD in Organizational Management and Leadership from Capella University, an MS in Pharmacology and Business Administration from Seton Hall University, and a BS in Medical Technology from Rutgers University - Newark.
This person is not in any teams
Regulus Therapeutics
1 followers
Regulus Therapeutics Inc. (Nasdaq:RGLS) is a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs.